Neoplasia

Article	Citations
Epitranscriptomic mechanisms of androgen signalling and prostate cancer	1628
Corrigendum to “Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells” [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549–562]	114
DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC	96
Corrigendum to “Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells” [Neoplasia 17 (2014) 85]	56
ARID1A loss sensitizes colorectal cancer cells to floxuridine	55
Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene	53
Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma	51
High metastatic tumor-derived CXCL16 mediates liver colonization metastasis by inducing Kupffer cell polarization via the PI3K/AKT/FOXO3a pathway	48
5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD	43
Sialylated IgG-activated integrin β4-Src-Erk axis stabilizes c-Myc in a p300 lysine acetyltransferase-dependent manner to promote colorectal cancer liver metastasis	42
The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells	41
L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling	41
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma	41
Retraction notice to “Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors” [Neoplasia 18 (2016) 347- 355/201]	40
Mutational signatures and their association with survival and gene expression in urological carcinomas	39
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy	39
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer	38
Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice	36
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy	36
Tumor-Infiltrating Immune Cells in Colorectal Cancer	35
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine	34
Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series	33
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism	31
Advanced progress of spatial metabolomics in head and neck cancer research	30
Rezatapopt: A promising small-molecule “refolder” specific for TP53Y220C mutant tumors	30

Leptomeningeal dissemination in pediatric brain tumors	30
Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations	28
Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations	26
Epigenetic DNA modifications and vitamin C in prostate cancer and benign prostatic hyperplasia: Exploring similarities, disparities, and pathogenic implications	26
Lactate promoted cisplatin resistance in NSCLC by modulating the m6A modification-mediated FOXO3/MAGI1-IT1/miR-664b-3p/IL-6R axis	26
The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities	25
STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications	24
Regulatory mechanisms of the Hippo/YAP axis by G-protein coupled estrogen receptor in gastric signet-ring cell carcinoma	24
Single-cell proteomic analysis reveals Multiple Myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced states	24
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients	24
Reciprocal regulation of lncRNA MEF and c-Myc drives colorectal cancer tumorigenesis	23
An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors	23
PDGF-BB overexpression in p53 null oligodendrocyte progenitors increases H3K27me3 and induces transcriptional changes which favor proliferation	22
Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation	22
β-Catenin mediated TAM phenotype promotes pancreatic cancer metastasis via the OSM/STAT3/LOXL2 axis	21
Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis	21
Aurkin-A, a TPX2-Aurora A small molecule inhibitor disrupts Alisertib-induced polyploidy in aggressive diffuse large B cell lymphoma	20
Incidence, mortality, and global burden of retinoblastoma in 204 countries worldwide from 1990 to 2021: Data and systematic analysis from the Global Burden of Disease Study 2021	20
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR	20
Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus	20
A systematic review of microbiome-derived biomarkers for early colorectal cancer detection	19
Aurora kinase B is required for growth and expansion of medulloblastoma cells in the tissue context	19
Evidence based on Mendelian randomization: Causal relationship between mitochondrial biological function and lung cancer and its subtypes	19
Corrigendum to “SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT Pathway” [Neoplasia (2021) 23, 1037–1047]	18
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment	18
Pediatric neuro-oncology: Highlights of the last quarter-century	18
Inhibiting HnRNP L-mediated alternative splicing of EIF4G1 counteracts immune checkpoint blockade resistance in Castration-resistant prostate Cancer	18
The DNA mismatch repair protein, MSH6 is a novel regulator of PD-L1 expression	18
Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature	17
Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)	17
Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement	17
HSP90 C-terminal domain inhibition promotes VDAC1 oligomerization via decreasing K274 mono-ubiquitination in Hepatocellular Carcinoma	16
Amelioration of muscle wasting by gintonin in cancer cachexia	16
Sustained experimental activation of FGF8/ERK in the developing chicken spinal cord models early events in ERK-mediated tumorigenesis	16
High dose acetaminophen re-polarizes CD11b+ cells in the tumor microenvironment towards an activated macrophage phenotype	16
SLC31A1 promotes chemoresistance through inducing CPT1A-mediated fatty acid oxidation in ER-positive breast cancer	16
BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer	15
IGDQ motogenic peptide gradient induces directional cell migration through integrin (αv)β3 activation in MDA-MB-231 metastatic breast cancer cells	15
MYH knockdown in pancreatic cancer cells creates an exploitable DNA repair vulnerability	15
Medication adjustment of afatinib and combination therapy with sitagliptin for alleviating afatinib-induced diarrhea in rats	15
A bioluminescence reporter mouse model for visualizing and quantifying CD8+ T cells in vivo	15
Whole-chromosome arm acquired uniparental disomy in cancer development is a consequence of isochromosome formation	15
Early separation and parallel clonal selection of dedifferentiated and well-differentiated components in dedifferentiated liposarcoma	15
Comparative effects of combustible cigarette versus electronic cigarette exposures on KRAS mutant lung cancer promotion	15
Spatial profiling of METex14-altered NSCLC under tepotinib treatment: Shifting the immunosuppressive landscape	15
Acral melanoma: new insights into the immune and genomic landscape	15
Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasia	15
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5	14
Carcinogenesis induced by space radiation: A systematic review	14
PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome	14

High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer	14
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma	14
PBI-05204, a supercritical CO2 extract of Nerium oleander, suppresses glioblastoma stem cells by inhibiting GRP78 and inducing programmed necroptotic cell death	14
Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening	14
Cell competition, cooperation, and cancer	13
Current state of pediatric neuro-oncology imaging, challenges and future directions	13
Impact of tissue penetration and albumin binding on design of T cell targeted bispecific agents	13
Corrigendum to “Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma” [Neoplasia, Volume 21, Issue 3 (2019) 322–330]	13
Corrigendum to “NFAT1 hypermethylation promotes epithelial‐mesenchymal transition and metastasis in nasopharyngeal carcinoma by activating ITGA6 transcription” [Neoplasia 21 (2019): 311–321]	13
Targeting myeloma metabolism: How abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors	13
Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton	13
Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada	13
Bacterial translocation and barrier dysfunction enhance colonic tumorigenesis	13
Genomics driven precision oncology in advanced biliary tract cancer improves survival	13
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor	13
Unveiling the impact of SUMOylation at K298 site of heat shock factor 1 on glioblastoma malignant progression	12
Combining selinexor with alisertib to target the p53 pathway in neuroblastoma	12
Therapeutic effiacy of T cells expressing chimeric antigen receptor derived from a mesothelin-specific scFv in orthotopic human pancreatic cancer animal models	12
Systemic inflammation in response to radiation drives the genesis of an immunosuppressed tumor microenvironment	12
Why haven't we solved intracranial pediatric ependymoma? Current questions and barriers to treatment advances.	12
LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44	11
CYP1B1 promotes angiogenesis and sunitinib resistance in clear cell renal cell carcinoma via USP5-mediated HIF2α deubiquitination	11
FAPα and αSMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma	11
Phase I clinical trial of a novel procaspase-3 activator SM-1 with temozolomide in recurrent high-grade gliomas	11
Motion based ex vivo (MOTEX) culture of breast tumor slices sustains microenvironment composition	11
CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation	11
DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study	11
Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma	11
Proteomic profiling of canine fibrosarcoma and adjacent peritumoral tissue	11
Corrigendum to “Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL” [Neoplasia. Vol. 9, No. 5, May 2007, pp. 435–442]	11
Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin	11
Furin, ADAM, and γ-secretase: Core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer	10
Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases	10
The renal clear cell carcinoma immune landscape	10
Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer	10
The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia	10
Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors	10
Corrigendum to “DNA-methylation eraser TET2 activates WTIP expression to suppress an AKT-dependent chemoresistance of gastric cancer” [Neoplasia volume 2025 Apr 24:65:101166]	10
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition	10
Metformin combined with cisplatin reduces anticancer activity via ATM/CHK2-dependent upregulation of Rad51 pathway in ovarian cancer	10
Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization	10
Differential prognostic association of systemic inflammatory biomarkers on survival outcomes in head and neck squamous cell carcinoma patients by human papillomavirus status	10
Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma	9
ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma	9
The TRIM22-CDT2 axis is the key mediator of the p53-Rb signals in growth control of HPV-positive cervical carcinoma cells	9
The antitumor activity of osimertinib plus palbociclib in non-small cell lung cancer patient-derived xenograft (PDX)/2D/3D culture models harboring EGFR amplification and CDKN2A/2B homozygous deletion	9
Maestros of malignancy: Microbes as the conductors of carcinogenesis	9
Targeting monopolar spindle kinase I (Mps1 or TTK) induces radiosensitization in syngeneic models of triple negative breast cancer (TNBC) and potentiates type I interferon (T1IFN) signaling	9
RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells	9
Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer	9
Deletion of the transcription factor ATF4 in a model of clear cell renal cell carcinoma	9
Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation induced by cooperation of MLL/AF10 with activating KRAS mutation in a mouse transplantation model	9
Multimodal profiling of oral squamous cell carcinoma identifies genomic alterations and expression programs associated with betel quid chewing	9
AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling	9
Saturated fat exacerbates mitochondrial dysfunction through remodelling of ATP production and inflammation in Barrett’s oesophagus compared to monounsaturated fat, particularly in contrast to oesophag	9
Clinical and genetic drivers of oligo-metastatic disease in colon cancer	9
Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma	9
Decoding androgen receptor signalling: Genomic vs. non-genomic roles in prostate cancer	9
Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy	8
Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells	8
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma –	8
Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma	8
Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments	8
RRM2 inhibition alters cell cycle through ATM/Rb/E2F1 pathway in atypical teratoid rhabdoid tumor	8
Cholesterol and saturated fatty acids synergistically promote the malignant progression of prostate cancer	8
High-dose DFMO alters protein translation in neuroblastoma	8
MYC alterations in multiple myeloma: Genetic insights and prognostic impact	8
RETRACTED: Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization	8
SCFβ-TrCP targets Ajuba for degradation in a GSK3β-dependent manner in colorectal cancer	8
Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotype	8
PRMT1 methylates METTL14 to modulate its oncogenic function	8
Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis	8
The promise of metabolic imaging in diffuse midline glioma	8
Modulation of mitochondrial function by extracellular acidosis in tumor cells and normal fibroblasts: Role of signaling pathways	8
Immunohistochemical and molecular evolutionary features of jejunoileal adenocarcinoma unveiled through comparative analysis with colorectal adenocarcinoma	8
Cardiac substructures dosimetric predicts cardiac toxicity and prognosis in esophageal squamous cell cancer treated by radiotherapy	8
circUBR5 promotes ribosome biogenesis and induces docetaxel resistance in triple-negative breast cancer cell lines via the miR-340-5p/CMTM6/c-MYC axis	8
LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice	7
Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model	7
Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape	7

Non-canonical olfactory pathway activation induces cell fusion of cervical cancer cells	7
IL-6 facilitates cross-talk between epithelial cells and tumor- associated macrophages in Helicobacter pylori-linked gastric carcinogenesis	7
The pan-cancer landscape of abnormal DNA methylation and intratumor microorganisms	6
Past, present and future of Focused Ultrasound as an adjunct or complement to DIPG/DMG therapy: A consensus of the 2021 FUSF DIPG meeting	6
Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferation	6
Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas	6
Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing	6
Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decision	6
Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function	6
Neuropilin-2 upregulation by stromal TGFβ1 induces lung disseminated tumor cells dormancy escape and promotes metastasis outgrowth	6
Microbial molecules, metabolites, and malignancy	6
Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma	6
An effective multistage mouse model of esophageal carcinogenesis for preclinical and computational pathology applications	6
Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC	6
The breast tissue microbiome, stroma, immune cells and breast cancer	6
Diet-microbiome interactions in cancer treatment: Opportunities and challenges for precision nutrition in cancer	6
In vivo two-photon characterization of tumor-associated macrophages and microglia (TAM/M) and CX3CR1 during different steps of brain metastasis formation from lung cancer	6
Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40	6
Depletion of β1,6-N-acetylglucosaminyltransferase reduces E-selectin binding capacity and migratory potential of human gastrointestinal adenocarcinoma cells	5
Kv11.1-dependent senescence activates a lethal immune response via tumor necrosis factor alpha	5
Tumor neoantigens as key drivers of significant anti - tumor immunity in triple - negative breast cancer mouse models	5
Sequential treatment of anti-PD-L1 therapy prior to anti-VEGFR2 therapy contributes to more significant clinical benefits in non-small cell lung cancer	5
Insights into the metastatic bone marrow niche gained from fibronectin and β1 integrin transgenic mice	5
Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system	5
Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer	5
An antibody targeting an immune checkpoint molecule BTN2A2 enhances anti-tumor immunity	5
Engineering and characterization of Hu3A4: A novel humanized antibody with potential as a therapeutic agent against myeloid lineage leukemias	5
Cell communication pathway prognostic model identified detrimental neurodevelopmental pathways in neuroblastoma	5
miRTARGET: An integrated web tool for the identification of microRNA targets with potential therapeutic or prognostic value in cancer	5
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer	5
Comparison of adjuvant gemcitabine plus S-1 with S-1 monotherapy for pancreatic ductal adenocarcinoma: Retrospective real-world data	5
S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas	5
Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma	5
Extracellular signals induce dynamic ER remodeling through αTAT1-dependent microtubule acetylation	5
MLH1 mediates cytoprotective nucleophagy to resist 5-Fluorouracil-induced cell death in colorectal carcinoma	5
PI3K-CCL2-CCR2-MDSCs axis: A potential pathway for tumor Clostridia-promoted CD 8+ T lymphocyte infiltration in bile tract cancers	4
Comparison of differences in transcriptional and genetic profiles between intra-central nervous system and extra-central nervous system large B-cell lymphoma	4
Exosomes in review: A new frontier in CAR-T cell therapies	4
Global molecular alterations involving recurrence or progression of pediatric brain tumors	4
GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors	4
Efficacy and safety of pyrotinib-based regimens in HER2 positive metastatic breast cancer: A retrospective real-world data study	4
Proteomic characterization of the pseudocapsule of clear cell renal cell carcinoma in VHL disease reveals a distinct microenvironment at the tumor boundary zone	4
Retraction notice to Corrigendum to “Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization” [Neoplasia 31 (2022) 100805]	4
Retraction notice to “Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization” [Neoplasia 27 (2022) 100784]	4
[18F]-FLT-PET to evaluate how the sequencing of chemotherapies impacts the efficacy of combination treatment in mouse models of triple-negative breast cancer	4
DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway	4
A synergistic approach for modulating the tumor microenvironment to enhance nano-immunotherapy in sarcomas	4
SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy	4
Corrigendum to Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1 α/miR-494/Survivin signaling pathway [Volume 32 Number xxx Month 2022 pp. 100821]	4
STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma	4
Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutaminase and glutamate export	4
Copy number alteration of the interferon gene cluster in cancer: Individual patient data meta-analysis prospects to personalized immunotherapy	4
Proteome biology of primary colorectal carcinoma and corresponding liver metastases	4
Characterization and integrated analysis of extrachromosomal DNA amplification in hematological malignancies	4
YPEL2 regulates the efficacy of BRD4-EZH2 dual targeting in EZH2Y641mut germinal center-derived lymphoma	4
Corrigendum to “Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E” [Neoplasia, volume 12,	4
Suppression of ER-stress induction of GRP78 as an anti-neoplastic mechanism of the cardiac glycoside Lanatoside C in pancreatic cancer	4
Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis	4
Influence of alectinib and crizotinib on ionizing radiation - in vitro analysis of ALK/ROS1-wildtype lung tissue cells	4
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis	4
Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer	4
Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection	4
Specifying the choice of EGFR-TKI based on brain metastatic status for advanced NSCLC with EGFR p.L861Q mutation	4
EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis	3
Transcriptomic and proteomic profiling identifies feline fibrosarcoma as clinically amenable model for aggressive sarcoma subtypes	3
Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells	3
Towards a molecular understanding of the overlapping and distinct roles of UBQLN1 and UBQLN2 in lung cancer progression and metastasis	3
Identification of 68 HLA-A24 and -A2-restricted cytotoxic T lymphocyte-inducing peptides derived from 10 common cancer-specific antigens frequently expressed in various solid cancers	3
PIK3R1 fusion drives chemoresistance in ovarian cancer by activating ERK1/2 and inducing rod and ring-like structures	3
Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma	3
Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients – Knowledge from two independent internation	3
A methyl-to-acetyl switch in H3K27 drives metabolic reprogramming and resistance to BRAFV600E inhibition in melanoma	3
Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era	3
Disitamab vedotin combined with toripalimab and radiotherapy for multimodal organ-sparing treatment of muscle invasive bladder cancer: a proof-of-concept study	3
Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats	3
Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis	3
True cancer stem cells exhibit relative degrees of dormancy and genomic stability	3
FABP4 facilitates epithelial-mesenchymal transition via elevating CD36 expression in glioma cells	3
Establishing a comprehensive panel of patient-derived xenograft models for high-grade endometrial carcinoma: molecular subtypes, genetic alterations, and therapeutic target profiling	3
Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways	3
RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer	3
Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer	3
Targeting IL-23 for the interception of obesity-associated colorectal cancer	3
Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis	3
Enhanced Apc adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells	3
Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer center	3
Effect of MisMatch repair deficiency on metastasis occurrence in a syngeneic mouse model	3
A trio of tumor suppressor miRNA downregulates CREB5 dependent transcription to modulate neoadjuvant hormonal therapy sensitivity	3
Corrigendum to “Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.” [Neoplasia Volume 23, Iss	3
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy	3
Altered endosomal-lysosomal biogenesis in melanoma	3
O-GlcNAc-modified HOXA9 suppresses ferroptosis via promoting UBR5-mediated SIRT6 degradation in nasopharyngeal carcinoma	3
Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology	3
Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance	3
Interdisciplinary care of children with diffuse midline glioma	3